As myeloid expansion occurs under many conditions without necessarily afflicting renal damage, it appears to be the combination of suPAR and high-risk variants of the APOL1 gene that triggers CKD, and not just the presence of suPAR alone. This evidence concerns the gene APOL1 and chronic kidney disease.